Gender differences in primary percutaneous coronary intervention outcomes in patients with ST-elevation myocardial infarction  by Barbosa, Roberto Ramos et al.
Rev Bras Cardiol Invasiva. 2015;23(2):96-101
Original Article
Gender differences in primary percutaneous coronary intervention outcomes 
in patients with ST-elevation myocardial infarction
Roberto Ramos Barbosaa,b,*, Valmin Ramos da Silvab, Renato Giestas Serpaa, Felipe Bortot Cesara,  
Vinicius Fraga Mauroa, Denis Moulin dos Reis Bayerla, Walkimar Ururay Gloria Velosoa,  
Roberto de Almeida Cesara, Pedro Abilio Ribeiro Resecka
a Hospital Evangélico de Vila Velha, Vila Velha, ES, Brazil 
b Escola Superior de Ciências da Santa Casa de Misericórdia, Vitória, ES, Brazil
A B S T R A C T
Background: Higher mortality is reported among women with ST-elevation myocardial infarction 
(STEMI). This study aimed to evaluate the clinical and angiographic profiles, as well as outcomes of 
patients submitted to primary percutaneous coronary intervention (pPCI), according to gender. 
Methods: Retrospective study that included patients with STEMI undergoing pPCI between March 2012 
and May 2013 at a regional referral center, followed from admission until hospital discharge or death. 
Results: 208 patients underwent pPCI, of whom 51 (24.5%) were women and 157 (75.5%) men. A significant 
difference was observed for age (65.5 ± 14.0 vs. 58.8 ± 11.0 years; p = 0.001), diabetes (43.1% vs. 24.8%; 
p = 0.02), Killip-Kimball class III/IV (7.0% vs. 17.6%; p = 0.02), pain-to-door time (181 ± 154 minutes 
vs. 125 ± 103 minutes; p = 0.004), and door-to-balloon time (181 ± 87 vs. 133 minutes ± 67 minutes; 
p = 0.001). The success of the procedure was similar (92.1% vs. 91.1%; p = 0.22). In-hospital mortality 
was higher for females (23.5% vs. 8.9%; p = 0.006). Multivariate analysis identified age ≥ 70 years 
(odds ratio - OR = 2.75; 95% confidence interval - 95% CI: 1.81–3.64; p = 0.029) and Killip-Kimball 
class III/IV (OR = 2.45; 95% CI: 1.49–4.02; p = 0.002) as independent predictors of mortality. 
Conclusions: Women with STEMI had a more severe clinical profile and longer pain-to-door and door-to-
balloon times than men. Females had higher in-hospital mortality after pPCI, but the female gender was 
not identified as an independent predictor of death.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Diferenças de gênero nos resultados da intervenção coronariana percutânea 
primária em pacientes com infarto do miocárdio com elevação de ST
R E S U M O
Introdução: Relata-se maior mortalidade no sexo feminino no infarto do miocárdio com supradesnivelamento 
de ST (IAMCST). Este estudo teve como objetivo avaliar os perfis clínico e angiográfico, e os resultados de 
pacientes submetidos à intervenção coronária percutânea primária (ICPp), de acordo com o sexo. 
Métodos: Estudo retrospectivo que incluiu pacientes com IAMCST submetidos à ICPp entre março de 2012 e 
maio de 2013, em um serviço de referência regional, acompanhados desde a admissão até a alta hospitalar 
ou o óbito. 
Resultados: Foram submetidos à ICPp 208 pacientes, sendo 51 (24,5%) mulheres e 157 (75,5%) homens. 
Observou-se diferença significativa para idade (65,5 ± 14,0 vs. 58,8 ± 11,0 anos; p = 0,001), diabetes (43,1% 
vs. 24,8%; p = 0,02), classificação de Killip-Kimbal III/IV (17,6% vs. 7,0%; p = 0,02), tempo dor-porta (181 ± 
154 minutos vs. 125 ± 103 minutos; p = 0,004) e tempo porta-balão (181 ± 133 minutos vs. 87 ± 67 minutos; 
p = 0,001). O sucesso do procedimento foi semelhante (92,1% vs. 91,1%; p = 0,22). A mortalidade hospitalar 
foi maior para o sexo feminino (23,5% vs. 8,9%; p = 0,006). Análise multivariada identificou como preditores 
independentes de mortalidade a idade ≥ 70 anos (odds ratio − OR = 2,75; intervalo de confiança de 95% − IC 
95% 1,81-3,64; p = 0,029) e a classe Killip-Kimbal III/IV (OR = 2,45; IC 95% 1,49-4,02; p = 0,002).
A R T I C L E  I N F O
Article history:
Received 31 December 2014 
Accepted 23 March 2015
Keywords:
Myocardial infarction
Percutaneous coronary intervention
Gender
Mortality
Palavras-chave:
Infarto do miocárdio
Intervenção coronária percutânea
Sexo
Mortalidade
0104-1843/© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. This is an open access article under the CC 
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
DOI of original article: http://dx.doi.org/10.1016/j.rbci.2015.12.006
* Corresponding author: Rua Vênus, s/n, Alecrim, CEP: 29118-060, Vila Velha, ES, Brazil. 
E-mail: roberto.rb@cardiol.br (R.R. Barbosa). 
Peer Review under the responsability of Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista.
 R.R. Barbosa et al. / Rev Bras Cardiol Invasiva. 2015;23(2):96-101 97
Conclusões: Mulheres com IAMCST apresentaram perfil clínico mais grave e tempos dor-porta e porta-
balão mais prolongados que homens. O sexo feminino apresentou maior mortalidade hospitalar após ICPp, 
porém o sexo feminino não foi identificado como preditor independente de óbito.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Acute myocardial infarction (AMI) is one of the leading causes of 
death in Brazil and requires well-established protocols for its mana-
gement, as well as human and technological capacity, which de-
mand ever-increasing financial resources.1
There is strong evidence from randomized clinical trials that 
primary percutaneous coronary intervention (pPCI) is associated 
with lower mortality, as well as lower rates of recurrent AMI and 
intracranial bleeding, when compared to fibrinolytic therapy.2 
When pPCI is feasible, it is recommended for all patients with ST-
-elevation acute myocardial infarction (STEMI) who can undergo 
the procedure within 90 minutes of the first medical contact, per-
formed by qualified professionals, provided that symptoms started 
within the last 12 hours. 
STEMI requires immediate identification by the medical team and 
prompt treatment, involving inter-hospital transfer in some of the ca-
ses and specific care services.3 At different points of care, there may 
be various types of accessibility barriers, usually having clinical, envi-
ronmental, social, cognitive, and/or emotional causes, and which 
may be closely related to gender. All these factors can interfere with 
the medical assessment and decision-making process, as well as the 
arrival to a health care service or site.4 
Several studies have identified different characteristics of STEMI 
in men and women. Higher mortality is often observed in women, in 
addition to adverse clinical characteristics at a higher frequency 
than in men, such as older age, higher prevalence of cardiovascular 
risk factors, and more severe clinical presentation.5-9 Moreover, lon-
ger delay in the care of women with STEMI has been reported, which 
could influence results, including patients undergoing pPCI.9 
This study aimed to evaluate the clinical and angiographic pro-
file pPCI and outcomes of patients undergoing pPCI according to 
gender, and to obtain the independent predictors of in-hospital 
mortality. 
Methods
Study design and population
This was a retrospective, observational, single-center, descripti-
ve, and comparative study (by gender), carried out with data collec-
ted from medical records and information obtained and recorded in 
in the Interventional Cardiology Laboratory. 
The sample consisted of consecutive patients admitted with STEMI 
and undergoing pPCI between March 2012 and May 2013, at a regio-
nal referral service, followed from admission until hospital dischar-
ge or death. The study included patients older than 18 years 
undergoing pPCI as an urgent procedure within the first 12 hours of 
symptom onset, treated through the Brazilian Unified Health Sys-
tem (Sistema Único de Saúde [SUS]), with persistent ST-segment ele-
vation in two or more contiguous leads or new left bundle branch 
block on the electrocardiogram. Patients undergoing PCI with symp-
tom onset for more than 12 hours were excluded, as well as those 
without STEMI diagnostic criteria at the joint assessment by the cli-
nical and interventional cardiology teams. 
Procedures
All cases of STEMI treated at the referral institution had spon-
taneous demand or were transferred after initial treatment and 
identification of the clinical picture in another service. The cases re-
quiring inter-hospital transfer were transported by the Mobile 
Emergency Care Service (SAMU - Serviço de Atendimento Móvel de 
Urgência), as recommended by the regulatory flow of the Urgency 
and Emergency Network of the State of Espírito Santo, Brazil. In such 
cases, the SAMU, contacted by the medical team of the first service 
after receiving the patient, performed the regulations, contacted the 
referral service, and conducted the subsequent transfer of the pa-
tient in an appropriate emergency transportation unit. 
The emergency nature of the pPCI procedure was taken into ac-
count for all patients, who were brought to the catheterization la-
boratory as soon as possible after notification by the emergency 
room staff. Patients received a loading dose of 200 to 300 mg of 
acetylsalicylic acid and 300 to 600 mg of clopidogrel, or 180 mg of 
ticagrelor. The use of morphine, sublingual/intravenous nitrate, or 
beta-blocker was at the discretion of the physician. All patients re-
ceived unfractionated heparin in the cath lab (70 to 100 U/kg). Af-
ter the procedure, dual antiplatelet therapy was maintained 
systematically in all patients. 
The pPCI was performed as recommended by the Brazilian STEMI 
guidelines,10 with the access route defined by the interventional car-
diologist. Pre- and post-dilation were performed according to the 
operator’s discretion, as well as the administration of glycoprotein 
IIb/IIIa inhibitors. 
Myocardial ischemia times were recorded on a routine basis, 
as well as the time courses of the different stages of medical care. 
The following were analyzed: pain-to-balloon time (interval be-
tween the onset of symptoms and the first balloon inf lation); 
pain-to-door time (interval from symptom onset to arrival at the 
first health care service); inter-hospital transfer time (time from 
arrival at the first health care service to the referral hospital); and 
door-to-balloon time (time between a patient’s arrival at the re-
ferral hospital and the first balloon inflation).
Definitions and outcomes
Length of hospital stay was recorded from the hospital admission 
day, considered as "day zero". The hospital stay analysis considered 
only the patients discharged to home, excluding those who died du-
ring the hospitalization period.
The primary endpoint was the occurrence of death from any cau-
se during hospital stay. Secondary outcomes were the occurrence of 
definite or probable stent thrombosis according to the criteria of the 
Academic Research Consortium,11 moderate or severe bleeding ac-
cording to the Global Utilization of Streptokinase and Tissue Plasmi-
nogen Activator for Occluded Coronary Arteries criteria (GUSTO)12 or 
acute renal failure (characterized by elevated serum creatinine 
> 50% from baseline or the need for dialysis).
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Statistical analysis 
Categorical variables were expressed as absolute frequency and 
percentage and compared using Pearson's chi-squared test or 
Fisher's exact test, as appropriate. Continuous variables were des-
cribed as mean and standard deviation and compared using Stu-
dent’s t-test. The obtained data were stored in a Microsoft Office 
spreadsheet. The analysis was performed using the software Sta-
tistical Package for the Social Sciences (SPSS), version 20.0 for Win-
dows, with p-values < 0.05 considered as statistically significant. 
The independent predictors of hospital mortality were obtained 
by multivariate analysis through binary logistic regression. In the 
model, the continuous variables were dichotomized, with the fe-
male gender, age ≥ 70 years, arterial hypertension, diabetes melli-
tus, smoking, chronic renal failure, Killip-Kimball class III/IV at 
admission, and pain-to-balloon time > 360 minutes used as cova-
riates, while the dependent variable was the occurrence of death 
during hospitalization. 
Results 
The female gender had higher prevalence of diabetes mellitus 
(43.1 vs. 24.8%; p = 0.02) and a higher proportion of patients with 
Killip-Kimball class III/IV (Table 1).
Of the 208 patients analyzed, 155 (74.5%) were initially treated at 
another service and transferred to undergo pPCI. There was a higher 
proportion of inter-hospital transfers among males (60.8 vs. 79.0%; 
p = 0.02). However, this study observed a longer delay for female pa-
tients regarding pain-to-door (181 ± 154 minutes; vs. 125 ± 103 mi-
nutes; p = 0.004) and door-to-balloon time (181 ± 133 minutes vs. 87 
± 67 minutes; p = 0.001).
In the total sample, the femoral approach for pPCI was used in 
195 procedures (93.7%), while the radial approach was used in the 
others. A total of 249 coronary stents were implanted, all bare-
-metal stents, with a mean of 1.2 ± 0.53 stent per patient. The left 
anterior descending artery was the most often treated vessel in 
both groups, and the complexity characteristics of treated lesions 
was not different between groups (Table 2). Pre- (84.3 vs. 78.3%; 
p = 0.35) and post-dilation (19.6 vs. 26%; p = 0.64) were also simi-
larly used between the groups, and a glycoprotein IIb/IIIa inhibi-
tor was administered more frequently in women (47.0 vs. 19.1%; 
p = 0.04). Flow disturbances (slow-flow or no-reflow) occurred in 
27.5% of women and 20.4% of men (p = 0.24). Procedural success 
rates showed no difference in the comparison between groups 
(92.1 vs. 91.1%; p = 0.22).
In-hospital mortality of the total sample was 12.5%, and the 
mean hospital length of stay was 9.1 ± 8.2 days. Higher mortality 
was observed among female patients (23.5 vs. 8.9%; p = 0.02). No 
stroke cases were diagnosed between groups. Definite/probable 
stent thrombosis rates (2.0 vs. 2.0%, p > 0.99) and moderate/severe 
bleeding rates (9.8 vs. 5.1%, p = 0.22) were not different between 
groups (Table 3). In the multivariate analysis, age and Killip-Kim-
ball class III/IV were identified as factors independently associated 
with mortality. The female gender was not an independent predic-
tor of in-hospital mortality (Table 4).
Discussion
In the 1990s, the MONICA (Multinational MONItoring of Trends 
and Determinants in CArdiovascular Disease) project of the World 
Health Organization issued important alerts to the medical 
community regarding the different characteristics and manage-
ment of cardiovascular disease in women. The study demonstra-
ted differences between the genders in AMI presentation and 
management. Women had a more severe clinical presentation 
than men (Killip-Kimball class III/IV: 11.7 vs. 7.3%; p = 0.003); took 
longer to get to the hospital (< 6 hours: 47 vs. 52%; 6 to 12 hours: 
11 vs. 11%; 12 to 24 hours: 7 vs. 7%; > 24 hours: 35 vs. 30%; 
p < 0.001); and received fewer therapeutic interventions (admi-
nistration of thrombolytic agents: 42 vs. 58%; p < 0.001). The pro-
portion of patients aged ≥ 75 years was higher in women when 
compared to men (35.1 vs. 17.2%; p < 0.001); 56% of men and 41% of 
women with AMI were admitted to the coronary care unit < 24 
hours (adjusted odds ratio - OR: 1.40; 95% confidence interval - 
95% CI: 1.26 to 1.56). In-hospital mortality was 16% for males and 
27% for females (OR: 0.83; 95% CI: 0.71-0.97).13
A large international study on the differences between genders in 
acute coronary syndromes, with the inclusion of over 12,000 patients, 
Table 1
Clinical characteristics.
Variables Gender p-value
Female 
(n = 51)
Male 
(n = 157)
Age, years 65.5 ± 14.0 58.8 ± 11.0 0.001
Age range (years), n (%) 0.02
≤ 49 9 (17.6) 30 (19.1)
50-59 8 (15.7) 58 (36.9)
60-69 13 (25.5) 41 (26.1)
≥ 70 21 (41.2) 28 (17.8)
Arterial hypertension, n (%) 40 (78.4) 110 (70.1) 0.24
Diabetes mellitus, n (%) 22 (43.1) 39 (24.8) 0.02
Dyslipidemia, n (%) 20 (39.2) 51 (32.5) 0.37
Smoking, n (%) 16 (31.4) 61 (38.8) 0.33
Chronic renal failure, n (%) 8 (15.7) 18 (11.5) 0.42
Previous PCI, n (%) 1 (2.0) 14 (8.9) 0.12
Previous CABG, n (%) 0 5 (3.2) 0.24
Killip-Kimball class, n (%) 0.03
I 36 (70.6) 134 (85.3)
II 6 (11.8) 12 (7.6)
III 3 (5.9) 1 (0.6)
IV 6 (11.8) 10 (6.4)
Time delay, minutes
Pain-to-door 181 ± 154 125 ± 103 0.004
Inter-hospital transfer 284 ± 206 272 ± 217 0.73
Door-to-balloon 181 ± 133 87 ± 67 0.001
Pain-to-balloon 550 ± 498 438 ± 340 0.07
PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft surgery.
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showed that women were older than men at the time of STEMI (69 vs. 
61 years; p < 0.001) and had significantly higher rates of high blood 
pressure, diabetes, and previous heart failure. They also had lower 
rates of previous AMI and were less likely to be smokers. Women 
had more complications during hospitalization and higher mortality 
at 30 days (6.0 vs. 4.0%; p < 0.001). After adjusting for baseline cha-
racteristics, the rate of death or reinfarction at 30 days was similar 
for men and women (p = 0.47).14 
Data from 4,347 patients hospitalized for AMI in France showed 
higher in-hospital mortality in women aged 30 to 67 years when 
compared to men in the same age group (11 vs. 5%; OR: 2.4; 95% CI: 
1.4-4.3; p = 0.003), where as no difference was observed between 
men and women in the older age group, namely 68 to 89 years (18 vs. 
16%; OR: 1.2; 95% CI: 0.9-1.7; p = 0.3). In addition to gender, another 
significant predictor of in-hospital mortality was the Killip-Kimball 
class at admission.7
It is known that the reduction in total myocardial ischemia time 
before coronary reperfusion in STEMI is associated with a decrease 
in adverse outcomes, including mortality.3,15 However, the Brazilian 
reality in AMI assistance commonly presents with unnecessary de-
lays and infrequent use of evidence-based therapies within an 
appropriate timeframe.16 This fact generates a large increase in mor-
bidity and mortality from cardiovascular diseases, affecting a large 
part of the economically active population and burdening the alrea-
dy scarce financial resources for health care.1
Currently, Brazilian cities generally do not have effective and agi-
le systems for AMI treatment, which cause significant delays in ac-
cess to referral services. In large cities, most patients first seek care 
at the Basic Health Units and then are transferred to a referral servi-
ce to receive adequate treatment, including coronary reperfusion 
therapy, which cause time delay in the treatment of AMI. Additio-
nally, self-medication and difficulty identifying the disease hinder 
the timely access to health care services.13 
Regional systems of care to optimize timeliness of reperfusion 
therapy for AMI are strongly recommended, and should be develo-
ped and implemented to promote reduction of delay times and im-
prove results in all subpopulations with STEMI. Patients with greater 
delay before treatment are usually older and have more co-morbidi-
Table 2
Angiographic characteristics.
Variables Gender p-value
Female 
(n = 51)
Male 
(n = 157)
Culprit vessels, n (%) 0.42
Left anterior descending artery 25 (49.0) 64 (40.8)
Left circumflex artery 9 (17.6) 31 (19.7)
Right coronary artery 17 (33.3) 59 (37.6)
Left main coronary artery 1 (2.0) 2 (1.3)
Multivessel disease, n (%) 16 (31.4) 40 (25.5) 0.41
Bifurcation lesion, n (%) 7 (13.7) 19 (12.1) 0.76
Saphenous vein graft lesion, n (%) 1 (2.0) 1 (0.6) 0.37
GPI IIb/IIIa use, n (%) 24 (47.0) 49 (19.1) 0.04
Pre-dilation, n (%) 43 (84.3) 123 (78.3) 0.35
Post-dilation, n (%) 15 (19.6) 41 (26.1) 0.64
Nominal stent diameter, mm 2.99 ± 0.41 3.07 ± 0.44 0.88
Nominal stent length, mm 21.3 ± 6.7 22.5 ± 6.5 0.86
Slow/no-reflow, n (%) 14 (27.5) 32 (20.4) 0.24
Procedural success, n (%) 47 (92.2) 143 (91.1) 0.29
GPI: glycoprotein inhibitor.
Table 3
In-hospital clinical outcomes.
Outcomes Gender p-value
Female 
(n = 51)
Male 
(n = 157)
In-hospital mortality, n (%) 12 (23.5) 14 (8.9) 0.02
Definite/probable stent thrombosis, n (%) 1 (2.0) 3 (2.0) > 0.99
Moderate or severe bleeding, n (%) 5 (9.8) 8 (5.1) 0.22
Acute renal failure, n (%) 8 (15.7) 16 (10.2) 0.28
Length of hospital stay, days 10.6 ± 9 8.6 ± 7 0.15
Table 4
In-hospital predictors of death after primary percutaneous coronary intervention.
Variable Odds ratio 95% confidence  interval p-value
Female gender 1.84 0.88-2.16 0.09
Age ≥ 70 years 2.75 1.81-3.64 0.03
Arterial hypertension 1.75 0.12-1.85 0.28
Diabetes mellitus 2.25 0.30-3.52 0.92
Smoking 0.82 0.18-1.08 0.77
Chronic renal failure 1.65 0.47-5.72 0.24
Killip-Kimball class III/IV 2.45 1.49-4.02 0.002
Pain-to-balloon time > 360 minutes 1.26 0.99-1.62 0.31
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ties. A delay > 6 hours from symptom onset to the pPCI may repre-
sent a nearly two-fold mortality increase compared to that observed 
when the delay is < 6 hours.17
Many of the accessibility barriers, quite poorly studied in the 
context of STEMI, are prominent in the female gender. Clinical and 
cultural characteristics, such as atypical clinical presentation, attri-
bution of symptoms to other health problems, and delay in seeking 
medical care, lead to the association between female gender and de-
layed AMI treatment.4 The door-to-balloon time in STEMI is often 
significantly greater in women when compared to men, as shown by 
Correia et al. (190 ± 86 minutes vs. 136 ± 49 minutes; p = 0.01).18
In the Brazilian population, the female gender has been recogni-
zed as an independent variable associated with in-hospital mortali-
ty (9.9% for the male gender vs. female, 23%; OR: 0.35; 95% CI: 
0.19-0.67; p = 0.001). Age and Killip-Kimball class have also been 
confirmed as variables independently associated with increased risk 
of death in STEMI.6
High clinical complexity was observed among the patients inclu-
ded in this study, with a high prevalence of cardiovascular risk fac-
tors. In addition to this risk profile, there was a great delay in 
coronary reperfusion by pPCI at the several stages of medical care. 
This resulted in high in-hospital mortality from STEMI, which re-
flects the needs of the entire health care system regarding STEMI 
care through the SUS, from primary prevention in primary care to 
the high-complexity cardiologic procedures.
Although the female group showed significantly higher in-hospi-
tal mortality than the male group, female gender was not an inde-
pendent predictor of death in this study. The small sample size may 
justify the absence of an independent association. Therefore, the 
high mortality observed in women was mainly due to significantly 
greater clinical severity, older age, and longer delay to treatment in 
this group, not associated to gender alone.
In addition to gender, other factors were evaluated for in-hospital 
mortality prediction after pPCI in this population. Among them, it 
was observed that the Killip-Kimball class III/IV at admission and 
age ≥ 70 years were independently associated to the event. Similar 
results were found for these variables in international studies, de-
monstrating the high risk of death in STEMI in cases of elderly pa-
tients and those with high clinical severity in different populations 
around the world.7,8
Thus, female patients should be considered regarding their pe-
culiarities in the presence of AMI or other cardiovascular disea-
ses, and this fact should be also emphasized in public health 
policies and society guidelines, as well as other populations who 
are at high cardiovascular risk and show significant growth, such 
as the elderly, patients with chronic kidney disease, and those 
with diabetes mellitus.
Study limitations
The patients evaluated in this study correspond only to those 
who underwent pPCI as coronary reperfusion therapy. A number of 
patients who did not undergo pPCI or thrombolytic therapy were not 
accounted for and, therefore, was excluded from this study, showing 
that the problem illustrates only a part of the patients that were ac-
tually treated, and that the systemic deficiencies are indeed even 
more significant. 
The restricted sample size limits the observed results; the conve-
nience sample represents only the population of patients treated in 
the service where the study was carried out during the given time 
period and may not represent other populations. 
Information bias associated with the assessed time periods may 
have occurred due to inaccuracies about the time of symptom onset 
reported by patients and families. Such deviation is inherent in the 
collected information and has been previously considered in a com-
prehensive analysis of pPCI results and pain-to-balloon times.19 
However, it reflects the factual difficulties found in clinical practice 
when caring for patients with AMI. The measurement of pain-to-
-balloon time used in the study, although subject to these biases, 
should be taken into account, as it reflects the result of joint actions 
in several critical points of STEMI care, including the identification 
of symptoms by the patient, accessibility to health services, and 
quality of emergency pre-hospital care. 
Conclusions
Female patients with ST-segment elevation myocardial infarction 
had more severe clinical profile and longer pain-to-door and door-
-to-balloon times than males. Women had higher in-hospital morta-
lity after primary percutaneous coronary intervention, but female 
gender was not identified as an independent predictor of death.
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